US President Trump has exempted Indian pharmaceuticals from new reciprocal tariffs, benefiting India’s pharmaceutical sector. This sector is vital for affordable medicines and economic stability, with the US market representing 30% of Indian exports.
Related Posts
Delhi-based tech CEO shares “peak Bengaluru” moment
Ananya Narang, CEO of Entourage, recently experienced a virtual receptionist at a Bengaluru hotel, calling it a ‘Peak Bengaluru’ moment. This tech-forward approach replaces physical […]
Army pushes for desi Pinaka rockets, to ink Rs 10,200 crore deals within this fiscal
The Army is set to finalize orders worth Rs 10,200 crore for the Pinaka rocket systems’ ammunition before the fiscal year ends. The contracts cover […]
Muizzu thanks India for aid; ‘will always give priority to Maldives’, says PM Modi
Maldives President Mohamed Muizzu thanked Prime Minister Narendra Modi for providing Rs 30 billion and a $400 million currency swap to help with Maldives’ foreign […]